AJOONI — Ajooni Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.30bn
- IN₹1.16bn
- IN₹801.15m
- 38
- 32
- 74
- 45
Annual cashflow statement for Ajooni Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.81 | 5.04 | 14.6 | 15.8 | 30 |
| Depreciation | |||||
| Non-Cash Items | 2.87 | 5.84 | 5.51 | 3.8 | -21.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -55 | -3.69 | 5.61 | -85.4 | -57 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -43.8 | 11.6 | 36.8 | -55.8 | -39.5 |
| Capital Expenditures | -14 | -35.3 | -21.2 | -28.6 | -56 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 18.8 | 1.17 | 2.27 | -130 | 132 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4.74 | -34.1 | -19 | -158 | 76.4 |
| Financing Cash Flow Items | -3.28 | -5.84 | -5.4 | -4.78 | -5.57 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 33 | 23.7 | -19.7 | 217 | -35.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.07 | 1.2 | -1.87 | 2.52 | 1.19 |